Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 165 entries
View as:

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project

Phase: N/A Priority: Normal
NCT ID: NCT06351228 Org: User:
Start: 03/30/24 End: 12/31/24 Due: 12/31/25

Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06528483 Org: User:
Start: 12/02/24 End: 12/31/29 Due: 12/31/30

The TI.VA Algorithm: A First-in-Humans Test.

Phase: N/A Priority: Normal
NCT ID: NCT05199883 Org: User:
Start: 12/01/20 End: 01/31/21 Due: 01/31/22

Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03083314 Org: User:
Start: 06/12/14 End: 12/04/20 Due: 12/04/21

Early Lung Cancer Detection in High Risk Individuals

Phase: N/A Priority: Normal
NCT ID: NCT02837809 Org: User:
Start: 09/30/05 End: 10/31/16 Due: 10/31/17

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Phase: N/A Priority: Normal
NCT ID: NCT05782400 Org: User:
Start: 02/28/23 End: 09/30/27 Due: 09/30/28

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

Phase: N/A Priority: Normal
NCT ID: NCT02479347 Org: User:
Start: 03/31/13 End: 09/30/16 Due: 09/30/17

PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

Phase: N/A Priority: Normal
NCT ID: NCT02086656 Org: User:
Start: 06/30/13 End: 03/30/17 Due: 03/30/18

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01620970 Org: User:
Start: 03/01/12 End: 06/01/13 Due: 06/01/14

A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens

Phase: N/A Priority: Normal
NCT ID: NCT01869335 Org: User:
Start: 05/31/13 End: 05/31/15 Due: 05/31/16

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03467178 Org: User:
Start: 07/30/18 End: 12/31/21 Due: 12/31/22

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01914900 Org: User:
Start: 06/30/12 End: 03/31/15 Due: 03/31/16

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Phase: N/A Priority: Normal
NCT ID: NCT07030569 Org: User:
Start: 02/01/24 End: 01/01/27 Due: 01/01/28

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02414009 Org: User:
Start: 09/30/14 End: 07/30/19 Due: 07/30/20

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

Phase: N/A Priority: Normal
NCT ID: NCT04403867 Org: User:
Start: 01/02/20 End: 01/31/27 Due: 01/31/28

Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05136326 Org: User:
Start: 12/01/21 End: 12/31/26 Due: 12/31/27

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Phase: N/A Priority: Normal
NCT ID: NCT04435964 Org: User:
Start: 06/25/20 End: 02/28/23 Due: 02/28/24

Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14

Phase: N/A Priority: Normal
NCT ID: NCT02857712 Org: User:
Start: 12/31/14 End: 01/31/19 Due: 01/31/20

Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02664974 Org: User:
Start: 12/31/08 End: 06/30/11 Due: 06/30/12

Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)

Phase: N/A Priority: Normal
NCT ID: NCT03943602 Org: User:
Start: 08/01/19 End: 09/01/22 Due: 09/01/23

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.

Phase: N/A Priority: Normal
NCT ID: NCT03103724 Org: User:
Start: 03/16/17 End: 04/23/21 Due: 04/23/22

Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)

Phase: N/A Priority: Normal
NCT ID: NCT05372302 Org: User:
Start: 07/08/21 End: 10/31/22 Due: 10/31/23

Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis

Phase: N/A Priority: Normal
NCT ID: NCT01503840 Org: User:
Start: 12/31/11 End: 07/31/12 Due: 07/31/13

Big Data for Quality of Life in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05315570 Org: User:
Start: 03/28/22 End: 06/01/25 Due: 06/01/26

Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01031875 Org: User:
Start: 12/31/09 End: 08/31/12 Due: 08/31/13